Canada: Market for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses 2024

Market Size for Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Canada

For the fourth consecutive year, the Canadian human and animal blood market recorded growth in sales value, which increased by X% to $X in 2022. Overall, consumption, however, saw a relatively flat trend pattern. Over the period under review, the market hit record highs in 2022 and is expected to retain growth in the immediate term.

Production of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses in Canada

In value terms, human and animal blood production expanded to $X in 2022 estimated in export price. In general, production showed a relatively flat trend pattern. The most prominent rate of growth was recorded in 2015 with an increase of X% against the previous year. Human and animal blood production peaked at $X in 2012; however, from 2013 to 2022, production remained at a lower figure.

Exports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Exports from Canada

Human and animal blood exports from Canada reduced sharply to X tons in 2022, declining by X% against 2021. Overall, exports, however, enjoyed a prominent increase. The growth pace was the most rapid in 2018 with an increase of X% against the previous year. As a result, the exports reached the peak of X tons. From 2019 to 2022, the growth of the exports remained at a lower figure.

In value terms, human and animal blood exports dropped notably to $X in 2022. In general, exports continue to indicate a slight contraction. The pace of growth appeared the most rapid in 2014 with an increase of X% against the previous year. As a result, the exports attained the peak of $X. From 2015 to 2022, the growth of the exports failed to regain momentum.

Exports by Country

The United States (X tons) was the main destination for human and animal blood exports from Canada, with a X% share of total exports. Moreover, human and animal blood exports to the United States exceeded the volume sent to the second major destination, South Korea (X tons), ninefold.

From 2012 to 2022, the average annual growth rate of volume to the United States totaled X%. Exports to the other major destinations recorded the following average annual rates of exports growth: South Korea (X% per year) and Australia (X% per year).

In value terms, the United States ($X) remains the key foreign market for human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses exports from Canada, comprising X% of total exports. The second position in the ranking was held by South Korea ($X), with a X% share of total exports.

From 2012 to 2022, the average annual growth rate of value to the United States stood at X%. Exports to the other major destinations recorded the following average annual rates of exports growth: South Korea (X% per year) and Australia (X% per year).

Export Prices by Country

The average human and animal blood export price stood at $X per ton in 2022, shrinking by X% against the previous year. Overall, the export price saw a deep downturn. The most prominent rate of growth was recorded in 2020 an increase of X%. Over the period under review, the average export prices hit record highs at $X per ton in 2012; however, from 2013 to 2022, the export prices remained at a lower figure.

Average prices varied noticeably for the major foreign markets. In 2022, amid the top suppliers, the country with the highest price was Australia ($X per ton), while the average price for exports to the United States ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Australia (X%), while the prices for the other major destinations experienced a decline.

Imports of Human Blood And Animal Blood Prepared For Therapeutic, Pophylactic Or Diagnostic Uses

Imports into Canada

In 2022, after two years of growth, there was significant decline in supplies from abroad of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses, when their volume decreased by X% to X tons. In general, imports, however, continue to indicate a buoyant increase. The pace of growth was the most pronounced in 2021 with an increase of X% against the previous year. As a result, imports attained the peak of X tons, and then declined in the following year.

In value terms, human and animal blood imports reduced slightly to $X in 2022. Over the period under review, imports, however, posted a strong expansion. The pace of growth appeared the most rapid in 2017 when imports increased by X%. Imports peaked at $X in 2021, and then reduced slightly in the following year.

Imports by Country

The United States (X tons), Ireland (X tons) and China (X tons) were the main suppliers of human and animal blood imports to Canada, together comprising X% of total imports. The UK, South Korea and France lagged somewhat behind, together accounting for a further X%.

From 2012 to 2022, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by South Korea (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, Ireland ($X) constituted the largest supplier of human blood and animal blood prepared for therapeutic, pophylactic or diagnostic uses to Canada, comprising X% of total imports. The second position in the ranking was held by the United States ($X), with a X% share of total imports. It was followed by the UK, with a X% share.

From 2012 to 2022, the average annual growth rate of value from Ireland totaled X%. The remaining supplying countries recorded the following average annual rates of imports growth: the United States (X% per year) and the UK (X% per year).

Import Prices by Country

The average human and animal blood import price stood at $X per ton in 2022, surging by X% against the previous year. In general, import price indicated a resilient increase from 2012 to 2022: its price increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, human and animal blood import price decreased by X% against 2020 indices. The pace of growth was the most pronounced in 2019 an increase of X% against the previous year. Over the period under review, average import prices hit record highs at $X per ton in 2020; however, from 2021 to 2022, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was the UK ($X per ton), while the price for the United States ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by France (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :